Cite

HARVARD Citation

    Tomita, Y. et al. (2020). BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis. Vaccine. 38 (41), pp. 6352-6356. [Online]. 
  
Back to record